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During the past 50 or more years, vast quan-
tities ofdiverse synthetic chemicals (xenobi-
otics) have entered the environment because
ofefforts to increase agricultural productivity
and because ofmodern industrial processes.
These chemicals include herbicides, insecti-
cides, fungicides, styrenes, polychlorinated
biphenyls, and penta- to nonylphenols (1-3).
Somexenobiotics have been shown to disrupt
normal endocrine functions, which leads to
aberrant development of female and male
reproductive tissues and results in decreased
fertility orsterility (1-3). An earlydocument-
ed case concerning the effects of these
endocrine-disrupting agents on reproduction
was the report that newly hatched herring
gull chicks collected in the Lake Ontario area,
a region highly contaminated with the pesti-
cide DDT, had altered reproductive systems
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with the steroidal regulation of the normal
development and function of the male and
female reproductive tracts. The initial step
in the mechanism of action of steroid hor-
mones is binding ofthe steroid to its recep-
tor or binding protein (24). To determine
whether xenobiotics might act through
steroid receptor or steroid binding protein
pathways, we examined the ability ofselect-
ed xenobiotics to inhibit the binding of
[3H]171-estradiol to the estrogen receptor
or to inhibit the binding of [PH]5a-dihy-
drotestosterone (5a-DHT) to the androgen
receptor, androgen-binding protein (ABP),
and sex hormone-binding globulin (SHBG).
Our data indicate that xenobiotics interact
selectively and specifically with steroid
receptors and binding proteins. Thus, the
endocrine-disrupting effects ofenvironmen-
tal xenobiotics may occur through multiple
steroid signaling pathways.
Materials and Methods
Selection ofXenobiotics
Xenobiotics were selected based on pub-
lished data that they had endocrine-disrupt-
ing, estrogenic, or antiandrogenic effects or
that they bind to estrogen or androgen
receptors (1,6,19,25). All xenobiotics were
prepared as 1.0 mM stock solutions in
absolute ethanol and used directly or dilut-
ed in absolute ethanol for use.
Sources ofReceptors and Binding
Proteins
Because large quantities ofthe receptors and
binding proteins were required to conduct
these studies, we obtained tissue and serum
containing these proteins from commercial
and other sources. Cytosols prepared from
frozen young rabbit uteri (PelFreez, Rogers,
AR) and frozen prostates from 21-day old
Sprague-Dawley rats (Harlan Bioproducts
for Science, Indianapolis, IN) were the
sources of estrogen and androgen receptor,
respectively. The tissues were stored at -80°C
until used. To prepare uterine cytosol, the
frozen tissues were weighed and pulverized,
and TE buffer (10 mM Tris-HCl, pH 7.5,
1.0 mM EDTA) 1:10 wt/vol was added to
the tissue fragments. The sample was then
homogenized using a Polytron (Brinkman
Instruments, Westbury, NY). The homo-
genate was then centrifuged for 1 hr at
249,000g; the supernatant is referred to as
cytosol. Frozen prostates were weighed and
homogenized (1:4 wt/vol) in TE buffer con-
taining 1.0 mM phenylmethylsulfanylfluo-
ride and 1 mg/ml antipain; cytosol was pre-
pared as for the uterus. Cytosol prepared
from adult Sprague-Dawley rat epididymides
homogenized in TE buffer (1:4 wt/vol) was
the source of ABP. Postpartum human
serum obtained from Vanderbilt Hospital
(Nashville, TN) was the source ofSHBG.
Sources ofXenobiotics and Steroids
Hexachlorocyclohexane [1a,2c,30(a),4a,
5a,61-hexachlorocyclohexane], - and y-iso-
mers; p,p'-DDT; methoxychlor [1,1,1-
trichloro-2,2 bis(p-methoxyphenyl)ethane];
dieldrin; and pentachlorophenol were
obtained from Sigma (St. Louis, MO).
Nonylphenol was obtained from Aldrich
(St. Louis, MO). Atrazine [6-chloro-N-
ethyl-N'-(1-methyl-ethyl)-1,3,5-triazine-2,4-
diamine], p,p'- DDE, and op'-DDT, were
from Chem Service (Westchester, PA).
Unlabeled estradiol and 5ac-dihydrotestos-
terone were from Steraloids (Wilton, NH),
and [3H]17f-estradiol (87 Ci/mmole) and
[3H]5ax-DHT (130 Ci/mmole) were from
Dupont/NEN (Boston, MA).
BindingAssays
Charcoal assay. Binding to the estrogen
receptor was assessed by incubating uterine
cytosol with 7 nM [3H] 171-estradiol.
Binding to the androgen receptor, ABP, and
SHBG was assessed by incubating rat
prostate cytosol, epididymal cytosol, or
human serum, respectively, with 7nM
[3H]5a-DHT. Samples were incubated (at
40C overnight for receptors, or for 4-6 hr
for ABP and SHBG) with 7 nM [3H]ligand
alone (total binding) or togetherwith a 100-
fold molar excess ofthe corresponding unla-
beled ligand to determine nonspecific bind-
ing. All assay tubes were brought up to a
final volume of0.5 ml with TE. Xenobiotics
were used as inhibitors at a concentration of
100 gM. This concentration is in the range
ofthose used by others for inhibition studies
with xenobiotics (19,23). When the ability
of xenobiotics to inhibit the binding of
[3H]steroids to their binding proteins was
studied, 10 gl ofethanol (the same volume
in which the xenobiotics were dissolved) was
added to the total and nonspecific binding
tubes. Thus, 2% ethanol was present in each
0.5 ml incubation. This amount ofethanol
decreased total binding to the receptors by
2-3% and decreased total binding to ABP
and SHBG by about 10% compared to
samples that contained no ethanol. The spe-
cific binding that occurred in the presence
ofethanol was set at 100% in those experi-
ments in which data are plotted as a per-
centage ofcontrol.
After the incubations were concluded,
binding of [3H]ligands to their binding
proteins was conducted using either the
charcoal assay (26) or sucrose gradient
ultracentrifugation (26). The charcoal assay
was performed by adding 0.5 ml of a dex-
tran (0.05%)-coated charcoal (0.5%) sus-
pension in TP to each sample tube. The
tubes were then agitated on a vortex mixer
for 6 sec and then either centrifuged imme-
diately for 5 min at 1,500g (ABP and
SHBG samples) or incubated on ice for 10
min and then centrifuged (receptor sam-
ples). The difference in postcharcoal incu-
bation time is to take into account the
rapid dissociation ofligand from ABP and
SHBG (27) and its slower dissociation
from the receptors (26). After centrifuga-
tion, the supernatants were decanted into
scintillation vials and the radioactivity in
the samples was counted.
Sucrose gradient analysis. For sucrose
gradient analysis, samples were incubated
as described above and extracted with pel-
lets from 1 ml ofcharcoal suspension (28),
and 300 gl aliquots of each sample were
applied to low ionic strength (0.01 M KCI)
5-20% sucrose gradients and processed as
previously described (28).
Competition studies. Samples (andro-
gen and estrogen receptors, ABP, SHBG)
were incubated with a saturating concen-
tration of [3H]physiological ligand (7 nM)
and increasing concentrations of unlabeled
physiological ligand or xenobiotic competi-
tor. After incubation at 4°C overnight
(receptors) or for 4 hr (ABP and SHBG),
the amount of bound radioactivity was
determined using the charcoal assay proce-
dure. The data were plotted as percentage
of control (specific binding in the absence
of competitor) versus the log of the com-
petitor concentration. The concentration
of competitor that inhibited specific bind-
ing by 50% is the IC50. To determine the
relative binding affinity (RBA) ofthe xeno-
biotics as compared to the physiological
ligand, the IC50 for the physiological ligand
was divided by the IC50 of the xenobiotic
and the dividend was multiplied by 100.
Determination ofdissociation half-
time. Samples were incubated with 7 nM
[3H]physiological ligand alone or with a
100-fold molar excess ofunlabeled physio-
logical ligand (to determine nonspecific
binding) at 40C overnight (receptors) or for
4-6 hr (ABP, SHBG). At the conclusion of
the incubation, unlabeled physiological lig-
and (35 9M) or xenobiotic (100 ,uM) was
added to each sample. At various times
after these additions, the amount ofbound
radioactivity was determined using the
charcoal assay procedure. The data were
plotted as specific radioactivity bound as a
percentage ofcontrol versus time. A regres-
sion line was fitted to the points and the
dissociation half-time (t1l2) was calculated
as previously described (27).
StatisticalAnalysis
The data were analyzed by one-way analysis
ofvariance followed by Duncan's multiple-
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range test (29). Results were considered sig-
nificant whenp<0.05. The data are present-
ed as the mean and the standard error ofthe
mean.
Results
Studies on the Estrogen Receptor
To screen xenobiotics for possible interac-
tion with the estrogen receptor, we deter-
mined their ability to inhibit 7 nM
[3H]17f-estradiol binding to the estrogen
receptor present in uterine cytosol using the
charcoal assay procedure. Figure 1 shows
our results. Specific estradiol binding to
cytosol occurred, which was completely
inhibited by 700 nM unlabeled estradiol.
Unlabeled (700 nM) 5a-DHT inhibited
binding by about 25%. Of the xenobiotics
tested (present at 100 ,uM), methoxychlor,
p,p'-DDT, p,p'-DDE, and pentachloro-
phenol inhibited estradiol binding to a small
(10%) but statistically significant extent. In
contrast, o,p'-DDT and nonylphenol caused
a dramatic decrease in [3H]17f-estradiol
binding: 60 and 75%, respectively. Estradiol
binding was not significantly decreased by
the y- or &-isomer of hexachlorocyclohexa-
ne, dieldrin, or atrazine.
Further evaluation ofxenobiotic effects
on estradiol binding to uterine cytosol was
conducted using sucrose gradient analysis
(Fig. 2). When uterine cytosol was incubated
with 7 nM [3H]170-estradiol alone, a single
peak ofmacromolecular-bound radioactivity
was detected. The peak had a sedimentation
coefficient ofabout 10 S, in reference to a
4.6 S bovine serum albumin (BSA) sedimen-
tation standard, which corresponds to that of
the estrogen receptor on low ionic strength,
5-20% sucrose gradients (28). Incubation in
the presence of 700 nM unlabeled estradiol
eliminated the peak. These data confirm that
the estradiol binding detected in uterine
cytosol is to the estrogen receptor. As in the
charcoal assay, nonylphenol was a highly
effective inhibitor of[3H]17p-estradiol bind-
ing to the receptor and pentachlorophenol
reduced [3H]17,-estradiol binding, butp,p'-
DDT and p,p'-DDE had little detectable
effect onpeakheights.
The ability of selected xenobiotics to
cause dissociation of[3H]173-estradiol from
its receptor compared to the physiological
ligand was tested. The addition ofunlabeled
estradiol (35 jiM) to the estrogen receptor
preparation that had been equilibrated with
7 nM [3H]17p-estradiol resulted in a time-
dependent decrease in the amount of
radioactivity associated with the receptor.
The t1/2 ofdissociation (Table 1) was calcu-
lated (27) to be about 40 hr, which is in
agreement with literature values (26).
Pentachlorophenol (100 jiM) resulted in a
dissociation rate that was indistinguishable
from that caused by estradiol (Table 1).
When 100 jiM nonylphenol was used, disso-
ciation of estradiol from its receptor was
more rapid(t112 approx7 hr; Table 1).
Studies on theAndrogen Receptor
In contrast to the minor effects of most of
the xenobiotics tested in inhibiting estradiol
binding to its receptor (Fig. 1), many xeno-
biotics inhibited [3H]5a-DHT binding to
prostate cytosol to a statistically significant
extent (Fig. 3). The most effective inhibitors
were the DDT derivatives, p,p'-DDE, o,p'-
DDT, and p,p'-DDT, which inhibited
binding by 100, 90, and 80%, respectively.
The hexachlorocyclohexane isomers, which
inhibited binding by about 50%, were the
next most potent inhibitors of [3H]5a-
DHT binding. Nonylphenol, which
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Figure 1. Inhibition of [3H117j-estradiol binding to the estrogen receptor (estrogen receptor source, uter-
ine cytosol) as determined by the charcoal assay procedure. Abbreviations: *E, specific binding of
[3HJ17P-estradiol; E, unlabeled estradiol; DHT, unlabeled 5a-dihydrotestosterone; Hg, hexachlorocyclo-
hexane-y, Hd, hexachlorocyclohexane-8; ME, methoxychlor; pDDT, p,p'-DDT; DDE; p,p'-DDE; oDDT, o,p'-
DDT; DIE; dieldrin; ATR, atrazine; PEN, pentachlorophenol; NON, nonylphenol. The data are plotted at con-
trol (%) in which the amount of specific binding of [3HJ17p-estradiol = 100%. The mean and the standard
error ofthe mean are plotted. The numbers in parentheses above the bars indicate the number of experi-
ments in which samples were assayed in triplicate.
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Figure 2. Sucrose gradient analysis of estradiol binding to the estrogen receptor. Abbreviations: *E, sam-
ple incubated with 13H]17,B-estradiol alone prior to sucrose gradient analysis; E, unlabeled estradiol;
pDDT, p,p'-DDT; PENT, pentachlorophenol; DDE, p,p'-DDE; NON, nonylphenol; BSA, bovine serum albu-
min.
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reduced [3H]171-estradiol binding to the
estrogen receptor by 75%, had no effect on
[3H]5a-DHT binding to androgen receptor
(Fig. 3), nor did methoxychlor or estradiol.
Dieldrin, atrazine, and pentachlorophenol
resulted in a statistically significant 30-40%
reduction in [3H]5a-DHT binding (Fig. 3).
Two considerations prompted us to
examine [3H]5a-DHT binding to prostate
cytosol by sucrose gradient analysis. First
was the report that the prostate contains a
steroid-binding protein other than the
androgen receptor that is fairly nonspecific
and not readily saturable (30). This protein
sediments on low ionic strength, 5-20%
sucrose gradients at approximately 3.7 S
(30) in contrast to the androgen receptor,
which sediments at approximately 8-10 S
(28). The second consideration was our
observation that in some experiments, p,p'-
DDE present at a concentration of 100
gM inhibited [3H]55a-DHT binding to
prostate cytosol to a greater extent than did
0.7-,uM 5a-DHT. These data suggested
that binding moieties other than the andro-
gen receptor might be present in some
prostate cytosol preparations.
Figure 4A shows the results of sucrose
gradient analysis of[3H]5ac-DHT binding to
cytosol made from a batch of 15 prostates. A
single symmetrical peak of bound [3H]50a-
DHT was detected that had a sedimentation
coefficient of 8-10 S (Fig. 4A). This peak,
which represents the androgen receptor, was
proceeded by exponentially decreasing
amounts of radioactivity representing
unbound ligand that was not removed by the
charcoal extraction procedure. The 8-10 S
Table 1. The effect of various compounds on the half-time of dissociation of [3H]physiological ligand from its
receptor or binding protein.
Compound
Protein E DHT NON PEN ME Hd DDE
ER 40 hr - 7 hr 40 hr -
AR - 15hr - - - - 15hr
ABP - 7mi - - - 70 min -
SHBG - 85 min 85 min 5 min ND - -
Abbreviations: E, 17p-estradiol; DHT, 5ax-dihydrotestosterone; NON, nonylphenol; PEN, pentachlorophe-
nol; ME, methoxychlor; Hd, hexachlorocyclohexane-6; DDE, o,p'-DDE; ER, estrogen receptor; AR, andro-
gen receptor; ABP, androgen-binding protein; SHBG, sex hormone-binding globulin.
Blank spaces indicate thatthese comparisons were not made.
ND, no detectable dissociation during the time studied.
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Figure 3. Inhibition of [3H]5ax-DHT binding to the androgen receptor (androgen receptor source, rat
prostate cytosol) as determined by the charcoal assay procedure. Abbreviations: *DHT, specific binding
of[3H]Sa-DHT to the receptor; E, estradiol; DHT, 5a-dihydrotestosterone; Hg, hexachlorocyclohexe-y, Hd,
hexachlorocyclohexane-6; ME, methoxychlor; pDDT, p,p'-DDT; DDE, p,p'-DDE; oDDT, o,p'-DDT; DIE,
Dieldrin; ATR, atrazine; PEN, pentachlorophenol; NON, nonylphenol. Specific binding of [3H]5a-DHT =
100%. The mean and the standard error ofthe mean are plotted. The numbers above the bars indicate the
number of experiments in which the samples were assayed in duplicate.
peak was eliminated when the sample was
incubated with [3H]5a-DHT and 0.7 ,uM
unlabeled 5a-DHT (Fig. 4A) and it was
gready reducedwhen samples were incubated
with 100 ,uM p,p'-DDE or 100-,uM p,p'-
DDT. No [3H]5a-DHT bindingwas detect-
ed in the 4 S region of the gradient where
specific or nonspecific binding to moieties
otherthan the receptorwould be present.
Analysis of a batch of cytosol prepared
from 15 other prostates yielded the results
shown in Figure 4B. In this case, macromol-
ecular-bound [3H]5a-DHT was detected in
both the 4 S and 8 S regions ofthe gradient.
Unlabeled 5a-DHT (0.7 jM) eliminated
[3H]5a-DHT binding to the androgen
receptor present in the 8-10 S region and
decreased, but did not eliminate, [3H]5a-
DHT binding to the 4-5 S component(s).
In contrast, p,p'-DDE (100 jiM) eliminated
[3H]5a-DHT binding to components in
both regions of the gradient (Fig. 4B).
Whether the 4-5 S component represents
the 3.7 S low affinity, high capacity prostate
binding protein reported by others (30) is
not known. The presence ofthis unknown
protein provides an explanation for our
observation that 100 jiMp,p'-DDE reduced
binding of [3H]55a-DHT to some prostate
cytosol preparations to a greater extent than
did 0.7 jiM unlabeled 5oc-DHT.
The ability ofp,p'-DDE to cause disso-
ciation of [3H]55a-DHT from the prostate
androgen receptor was determined as
described above for the estrogen receptor.
Our data (Table 1) indicate that unlabeled
5at-DHT andp,p'-DDE resulted in a simi-
lar pattern ofdissociation of [3H]5ct-DHT
from the androgen receptor and a t 1/2 of
greater than 15 hr, a value that is in agree-
ment with the literature (31).
Studies onAndrogen-binding
Protein
Charcoal assay analysis of [3H]5ac-DHT
binding to rat epididymal cytosol contain-
ing ABP indicated that several xenobiotics
resulted in a statistically significant reduc-
tion in the amount of[3H]5a-DHT bound
to ABP (Fig. 5). The most effective xenobi-
otic inhibitor was the 6-isomer of hexa-
chlorocyclohexane, which caused a 70%
decrease in bound [3H]5ac-DHT. In con-
trast, the inhibition caused by the y-isomer
ofhexachlorocyclohexane did not reach sta-
tistical significance. Methoxychlor, p,p'-
DDT, and atrazine all reduced [3H]5a-
DHT binding to ABP by 40-50% (Fig. 5).
p,p'-DDE reduced binding to ABP by 20%.
Estradiol inhibited [3H]5ac-DHT binding
to ABP by about 60%.
Sucrose gradient analysis indicated that
macromolecular-bound [3H]5ac-DHT in
epididymal cytosol sedimented at 4.6 S as
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would be expected for ABP (32). This
binding was completely inhibited by unla-
beled 5a-DHT, reduced by hexachlorocy-
clohexane-6, but not affected by hexa-
chlorocyclohexane-,y (Fig. 6).
When the 6-isomer ofhexachlorocyclo-
hexane was used in dissociation studies, we
noted that the dissociation rate (t1/2 approx
70 min) was slower than the t1/2 ofabout 7
min obtained when unlabeled 5a-DHT was
used (Table 1). This latter value is similar to
whatwe have previously reported (27,32).
Studies on Sex Honnone-binding
Globulin
When the binding of [3H]5a-DHT to
human postpartum serum containing
SHBG was examined using the charcoal
assay procedure, we noted that the xenobi-
otics hexachlorocyclohexane-6 and y, o,p'-
DDT, pentachlorophenol, and nonylphe-
nol caused a statistically significant reduc-
tion in specific binding (Fig. 7).
Nonylphenol resulted in a 70% decrease in
[3H]5a-DHT binding, whereas the other
xenobiotic competitors reduced binding by
about 20-30%. SHBG was the least
responsive protein to the inhibitory effects
of xenobiotics on 5a-DHT binding.
Methoxychlor, p,p'-DDT,p,p'-DDE, dield-
rin, and atrazine were ineffective at inhibit-
ing [3H]5a-DHT binding to SHBG.
Estradiol inhibited [3H]5a-DHT binding
to SHBG by 85% (Fig. 7).
When the binding of [3H]5a-DHT to
serum components was examined by sucrose
gradient ultracentrifugation, label was bound
to a moiety sedimenting at 4.6 S, which is
the appropriate sedimentation coefficient for
SHBG (33). As expected, unlabeled 5a-
DHT and nonylphenol inhibited [3H]5a-
DHT binding to SHBG, whereas atrazine
did not (Fig. 8).
When dissociation studies were conduct-
ed, the addition of unlabeled 5a-DHT to
SHBG samples that had been equilibrated
with [3H]5a-DHT resulted in a t1/2 ofdisso-
ciation oflabel ofapproximately 85 min, a
t1/2 similar to literature values (27).
Nonylphenol resulted in asimilar dissociation
half-time, butpentachlorophenol resulted in a
more rapid dissociation rate (t1/2 approx 5
min). Methoxychlor, which had no effect on
steroid binding to hSHBG, did not effect the
dissociation of [3H]5a-DHT from SHBG
duringthe timeperiodstudied (Table 1).
Concentration ofLigand Causing a
50% Inhibition ofBinding
to Receptors and Binding Proteins
To further evaluate the affinity ofxenobi-
otics for steroid receptors and binding pro-
teins, competition studies were conducted
using multiple concentrations of competi-
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Figure 4. Analysis of[3H]5x-DHT binding tothe androgen receptor using sucrose gradient ultracentrifuga-
tion. Abbreviations: *DHT, sample incubated with PH]5a-DHT alone prior to sucrose gradient analysis;
DHT, 5a-DHT; DDE, p,p'-DDE; pDDT, p,p'-DDT. (A) Cytosol from one batch of prostateswas incubated with
[3HI5a-DHT alone, with unlabeled DHT, or with the indicated xenobiotics. (B) Cytosol from another batch
of prostates was incubated as in A.
tors. As indicated in Table 2, nanomolar
concentrations ofunlabeledphysiological lig-
and were able to reduce the binding of [H]
ligand to its corresponding receptor or bind-
ing protein by 50%. In contrast, micromolar
concentrations ofxenobiotics were required
to cause a 50% decrease in binding of [3H]
physiological ligands. The concentration of
p,p'-DDE that we found to be effective in
causing a 50% inhibition of[3H] 5a-DHT
binding to the androgen receptor (6.8 gM)
is similar to the 5 ,uM reported by Kelce et
al. (19) in their studies on the androgen
receptor. Our values for the IC50 of op'-
DDT for the estrogen receptor is in the
range of the values reported by others (23),
using different xenobiotics, for this receptor.
We are not aware ofpublished data on the
inhibition ofphysiological ligand binding to
ABP orSHBG byxenobiotics.
Discussion
Our experiments demonstrate that xenobi-
otics interact in a specific and differential
manner with the estrogen receptor, andro-
gen receptor, ABP, and SHBG.
Several xenobiotics were more capable
ofinhibiting [3H]5a-DHT binding to the
androgen receptor than to any ofthe other
proteins studied. This finding strongly sug-
gests that multiple xenobiotics acting
through the androgen receptor-mediated
pathway may be capable of disrupting
physiological processes regulated by this
pathway. Whether these compounds would
act in vivo as agonists or antagonists of
androgen action remains to be determined.
The study ofKelce et al. (19) reports that
p,p'-DDE inhibits androgen binding to the
androgen receptor, androgen-induced tran-
scriptional activity, and normal male pre-
pubertal development. Our data indicate
thatp,p'-DDE was the most potent ofthe
xenobiotics tested at inhibiting [3H]5a-
DHT binding to the androgen receptor.
Our study indicates that p,p'-DDT and
o,p'-DDT are also potent inhibitors of
[3H]55a-DHT binding to the androgen
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1-l";;,binding to human SHBG. On theother
hand, nonyiphenol was a better competitor
ABP. This finding is consistent with our
~~~ bservation (Fig. 5) and reo thelier
~~~~~ature (27) that human SHBG binds estra-
.......... ... ...... .;...diol better than ABP in rat epididym al ...-, ~~~~~~~~~~~~~~~~~~~~~~~~~~~~cytosol. Whether the effects ofxenobiotics
on androgen binding to human ABP are
more similar to those on binding to rat
~~~~~~~~~~~~ABP or to human SHBG remains to be
M;:= s,tt f'tJ Lit sL
U u!xdetermined. ABP and SHBG wereln
~~~~~~~~~~~~~~considered to be simply steroid transport
1 sM:: ~~~~~~~~~~~~~proteinsin the testis-epididymis and in the
s~~~:. ~ ~ .general circulation, respectively. Evidence
now exists demonstrating cell-surface
receptors for these proteins (37-38). ABP
E~~ ~ ~ ~ ~ ~ ~ ~~~ ~~~~ad SHBG bind to their receptors and acti-
~~~~~~~vate adenylyl cyclase (39)~. Xenobiotics that
bind to these proteins could prevent them
from binding to their receptors and/or they
~~~~~~~~could inhibit normal signal transduction,
~~~~thus disrupting the action ofthese proteins.
*DHT E DHT Hg Hd ME pDDT DDE oDDT DIE ATR PEN NON Of the xenobiotics tested, fewer inter-
LInhibition of[3HI5a-DHT binding to androgen-binding protein (ABP; source, cytosol from ratepi- atdwt
the and
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ine-a; ME, methoxychior; pDDT, p,p'-DDT; DDE, p,p'-DDE; oDDT, o,p'-DDT; DIE, dieldrin; ATR, [3H]17f3-estradiol binding to the estrogen i;PEN, pentachiorophenol; NON, nonyiphenol. Specific binding of*DHT = 100%. The mean and the receptor and its inhibition was not statisti- derror of the mean are plotted. The numbers above the bars indicate the number of experiments cally different than that caused by the ithe samples were assayed in triplicate. known estrogen mimetic, o,p'-DDT. Nonylphenol has been shown to induce proliferation of human breast cancer cells 0 DHT and to trigger mitotic activity in the rat
0 lid ~ endometrium (40). Nonylphenol has been shown to inhibit [3H]17j3-estradiol binding to the estrogen receptor present in rainbow trout and to stimulate vitellogenin gene expression in this species (41). Because nonylphenol does not inhibit [3H]5a- DHT binding to the androgen receptor, it may cause the in vitro effects solely through the estrogen receptor. However, since the experiments reported used human or fetal bovine (40,41) serum, both of which con- tain SHBG (42), in cultures with the cells,
0 4 8 8 10 12 14 16 18 20 22 24 some effects ofnonyiphenol acting through
Fraction number SHBG cannot be discounted. In vivo
endocrine-disrupting effects ofnonylphenol
S. Sucrose gradient analysis of [3H]5ax-DHT binding to androgen-binding protein (ABP; source, in species that possess SHBG are likely to
rat epididymides). Abbreviations: *DHT, cytosol incubated with [3HJ5ac-DHT alone; DHT, 5az-dihy- be mediated through both the estrogen )sterone; Hd, hexachlorocyclohexane-8; Hg, hexachlorocyclohexane-'y. receptor and SHBG.
We also studied the ability of xenobi-
ir. o,p'-DDT is usually considered to differ considerably in the oligosaccharides otics to influence the half-time ofdissocia-
ogenic (34), but our data suggests attached to them (36). Differences in tion of [3H]ligand from the proteins. The
could also be expected to act in an steroid-binding between rat ABP and data that we obtained indicate that while
enic orantiandrogenic manner. human SHBG have been observed (27). In some xenobiotics resulted in dissociation
th the 6- and y-isomers of hexa- addition to differential binding of hexa- rates identical to those caused by the physi-
,yclohexane are poetihibitors of chlorocyclohexane isomers to ABP and ological ligand, others resulted in more
X-DHT binding to the androgen SHBG, other binding differences between rapid or in slower rates. These data suggest
)r. These compounds bind to rat the proteins were noted. Methoxychlor and that some xenobiotics have a three-dimen-
iut not to human SHBG, in a stere- p,p'-DDT caused approximately a 40% tional structure that permits access to the
Pic manner. ABP and SHBG are reduction in binding to ABP, but had no binding site equivalent to that ofthe natur-
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Figure 7. The effect of xenobiotics on binding of [3H]5a-DHT to human sex hormone-binding globulin
(hSHBG; source, human serum). Abbreviations: *DHT, [3H]5a-DHT, E, estradiol; DHT, 5a-dihydrotestos-
terone; Hg, hexachlorocyclohexane-y Hd, hexachiorocyclohexane-8 ME, methoxychlor; pDDT, pp'-DDT;
DDE, p,p'-DDE; oDDT, o,p'-DDT; DIE, dieldrin;ATR, atrazine; PEN, pentachiorophenol; NON,nonyiphenol.
Specific binding of *DHT = 100%. The mean and standard error of the mean are plotted. The numbers
above the bars indicate the number of experiments in which the samples were assayed in triplicate.
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Figure 8. Sucrose gradient analysis of [3HJ5a-DHT binding to human sex hormone-binding globulin
(hSHBG; source, human serum). Abbreviations: *DHT, serum incubated with [3HJ5a-DHT alone prior to
gradientanaylysis; DHT, 5a-dihydrotestosterone; ATR, atrazine; NON, nonylphenol.
TableZ Relative binding affinity(RBA) andIC50ofxenobiotics forsteriod receptors and binding proteins
Competitor
Protein DHT E DDE oDDT Hg Hd
ER - 100(2.7 nM) - 0.007 (40gM)
AR 100(1.1 nM) - 0.016(6.8 IM) - -
ABP 100(9nM) - - - - 0.025(38gM)
SHBG 100(1.2nM) - - - 0.0007 (160 M) -
The numbers in parentheses indicate the molar concentrations of competitors thatreduced specific bind-
ing by 50% (IC50); blanks indicate that these comparisons were not made. Abbreviations: DHT, 5a-dihy-
drotestosterone; E, estradiol; DDE, pp'-DDE; oDDT, op'-DDT; Hg, hexachlorocyclohexane-y, Hd, hexa-
chlorocyclohexane-6; ER, estrogen receptor; AR, androgen receptor; ABP, androgen-binding protein;
SHBG, sexhormone-binding globulin.
xenobiotics facilitates or hinders this access.
Alternatively, it is possible that those xeno-
biotics that result in a more rapid dissocia-
tion rate than the physiological ligand, for
example, nonylphenol with the estrogen
receptor and pentachlorophenol with
SHBG, may be forming adducts with the
binding site preventing reassociation ofthe
labeled ligand or causing denaturation of
the proteins. Both scenarios would result in
an apparent increase in dissociation rate. If
this is the case, the effects must be protein-
specific because pentachlorophenol does
not increase the dissociation rate of
[3H]17J-estradiol from the estrogen recep-
tor, nor does nonylphenol increase the rate
of dissociation of [3H]5a-DHT from
SHBG. Hexachlorocyclohexane-6 results in
a slower rate of dissociation of [3H]5cc-
DHT from ABP than does unlabeled 5a-
DHT, a phenomenon that would be
incompatible with denaturation ofthe pro-
tein by the xenobiotic. Although we cannot
discount the possibility that the apparent
inhibition ofbinding caused by some xeno-
biotics is actually the result of the denatu-
ration or adduct formation, the multiple
point competition data are consistent with
our contention that several xenobiotics
compete with physiological ligands for sites
on steroid receptors and binding proteins.
Our data indicate that some xenobi-
otics, especially DDT congeners, can inter-
fere with the binding ofnatural ligands to
two or more binding moieties, thus ampli-
fying their potential endocrine-disrupting
effects. These data indicating that a xenobi-
otic may affect multiple signaling pathways
coupled with data showing synergistic
effects ofmultiple xenobiotics- on estrogen
responsive genes (23) should reinforce the
concept that environmental xenobiotics,
though present at low concentrations, may
pose a threat to human health.
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